Supercentenarians – reprogramming cellsAuthor: Phil Newman | Published on: April 28, 2020 | Last updated: May 10, 2022 Michael D WestChief Executive Officer, AgeX TherapeuticsSupercentenarians – reprogramming cellsShare this article: Editor's choiceWill proteomics provide the answers to aging and longevity?Don’t wait for longevity drugs – take action todayScientific leaders issue global Dublin Longevity Declaration‘Data-driven health is going to be the biggest revolution in the history of medicine’Leveraging the past to illuminate longevity for the future‘It’s always too early to say something’s impossible’Popular articlesLongevity investment bulletin: NewLimit, ORA, Insilico Medicine and moreStay cool: the longevity tech that “shows insane promise”Does SIRT6 hold the key to human longevity?Tally up! Consumer longevity company lands $10mLongevity: ‘money-spinning cult’ or the future of health?Zuzalu: a pop-up city with longevity at its heart
